IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

FINAZZI, MARIA CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.003
NA - Nord America 2.533
AS - Asia 2.118
SA - Sud America 208
Continente sconosciuto - Info sul continente non disponibili 189
AF - Africa 51
OC - Oceania 26
Totale 8.128
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.429
DE - Germania 1.253
IT - Italia 610
CN - Cina 579
SG - Singapore 500
JP - Giappone 270
GB - Regno Unito 265
BD - Bangladesh 199
BR - Brasile 132
VN - Vietnam 128
RU - Federazione Russa 127
FR - Francia 117
HK - Hong Kong 110
IN - India 104
NL - Olanda 95
SE - Svezia 85
ES - Italia 78
IE - Irlanda 69
CA - Canada 60
PL - Polonia 50
FI - Finlandia 49
ID - Indonesia 43
CH - Svizzera 35
AT - Austria 32
TW - Taiwan 32
KR - Corea 30
DK - Danimarca 29
TR - Turchia 24
MX - Messico 22
AR - Argentina 21
CO - Colombia 21
AU - Australia 17
SA - Arabia Saudita 17
CL - Cile 16
RS - Serbia 15
UA - Ucraina 14
CI - Costa d'Avorio 13
GR - Grecia 13
TH - Thailandia 13
HR - Croazia 11
IL - Israele 11
BE - Belgio 10
PH - Filippine 10
NZ - Nuova Zelanda 9
CZ - Repubblica Ceca 8
EG - Egitto 8
MA - Marocco 8
IQ - Iraq 7
SI - Slovenia 7
EC - Ecuador 6
HN - Honduras 6
MY - Malesia 6
PT - Portogallo 6
RO - Romania 6
ZA - Sudafrica 6
BG - Bulgaria 5
IM - Isola di Man 5
IR - Iran 5
JM - Giamaica 4
UY - Uruguay 4
GT - Guatemala 3
KZ - Kazakistan 3
LB - Libano 3
SC - Seychelles 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
DZ - Algeria 2
GE - Georgia 2
KE - Kenya 2
KH - Cambogia 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PK - Pakistan 2
PY - Paraguay 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
UG - Uganda 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GH - Ghana 1
KG - Kirghizistan 1
LV - Lettonia 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
Totale 7.936
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 1.091
Singapore 272
Ashburn 243
Southend 162
Milan 154
Dallas 139
Chandler 129
San Jose 111
Beijing 109
Hong Kong 98
Santa Clara 87
Fairfield 84
Council Bluffs 78
Dublin 68
New York 64
Tokyo 62
Los Angeles 59
Princeton 54
Seattle 52
Redwood City 51
Wilmington 48
Rome 42
Buffalo 40
Ho Chi Minh City 40
Hefei 38
Hanover 36
Houston 36
Bengaluru 33
Woodbridge 33
Helsinki 32
Lauterbourg 31
Tianjin 31
Hanoi 30
Moscow 29
Jakarta 26
Cambridge 25
Madrid 25
Guangzhou 24
Ann Arbor 23
Shanghai 22
Boston 20
Brooklyn 20
Chicago 20
Bologna 19
London 19
São Paulo 19
Vienna 19
Naples 17
Washington 17
Taipei 16
Warsaw 16
Atlanta 15
Des Moines 15
Hangzhou 15
Toronto 15
Cangzhou 14
Dong Ket 14
Seoul 14
Abidjan 13
Bergamo 13
Fremont 13
Montreal 13
Nanjing 13
Rochester 13
Santiago 13
Hyderabad 12
Jeddah 12
Krakow 12
Messina 12
Queens 12
Amsterdam 11
Boardman 11
Bogotá 11
Munich 11
Adachi 10
Barcelona 10
Berlin 10
Denver 10
Nuremberg 10
Phoenix 10
Belgrade 9
Birmingham 9
Cattolica 9
Columbus 9
Florence 9
Genoa 9
Wroclaw 9
Brescia 8
Changsha 8
Iowa City 8
Osaka 8
Reston 8
San Diego 8
Sunnyvale 8
Sydney 8
Baltimore 7
Bangkok 7
Brussels 7
Chennai 7
Da Nang 7
Totale 4.532
Salva come PNG Salva come JPEG
Nome #
A reappraisal of the benefit-risk profile of hydroxyurea in polycythemia vera : a propensity-matched study 1.407
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms : an European Leukemia Net study 607
A multistate model of survival prediction and event monitoring in prefibrotic myelofibrosis 444
Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera 282
Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia : a report from the MPN subcommittee of the chronic malignancies working party of the European group for blood and marrow transplantation 275
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial 265
Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis 262
A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis 259
Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients 253
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea 237
Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms 227
Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts 211
Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT 210
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes 203
Busulfan or thiotepa based conditioning in myelofibrosis: A phase II multicenter randomized study from the GITMO group 202
Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: Update of the ERNEST Study 199
Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score 198
Second primary malignancies in ruxolitinib-treated myelofibrosis : real-world evidence from 219 consecutive patients 185
A pilot study of the Histone-Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms 175
A novel method using blinatumomab for efficient, clinical-grade expansion of polyclonal T cells for adoptive immunotherapy 174
Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience 167
Characteristics of graft-versus-host disease occurring after alemtuzumab-containing allogeneic stem cell transplants: incidence, organ involvement, risk factors and survival 163
A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis 161
CALR mutation, MPL mutation and triple negativity identify patients with the lowest vascular risk in primary myelofibrosis 148
Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation 142
Molecular prognostication for transplant decision making of patients with myelodysplastic syndromes: A retrospective single-center study 138
A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy 138
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with Vitamin K antagonists 137
Pre-existing immune checkpoints activation predicts relapse after allogeneic stem cell transplantation in lymphoma 133
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN 120
Clonal Hematopoiesis in Myeloproliferative Neoplasms Confers a Predisposition to both Thrombosis and Cancer 115
Rituximab added to conditioning regimen significantly improves erythroid engraftment in major incompatible ABO-group hematopoietic stem cell transplantation 111
Detection of driver and subclonal mutations in myelofibrosis : clinical impact on pharmacologic and transplant based treatment strategies 108
Front-line therapy in polycythemia vera and essential thrombocythemia 72
Totale 8.128
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.407
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.407
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022557 0 0 67 53 58 34 37 41 81 67 39 80
2022/2023678 57 51 64 58 64 100 22 60 92 22 53 35
2023/20241.378 38 63 47 57 118 49 187 180 97 152 204 186
2024/20251.685 170 200 164 149 109 93 85 95 88 188 115 229
2025/20262.239 200 225 184 166 213 132 244 87 203 141 244 200
2026/2027502 149 319 34 0 0 0 0 0 0 0 0 0
Totale 8.128